Article History
Received: 17 April 2018
Accepted: 25 April 2019
First Online: 7 May 2019
Ethics approval and consent to participate
: N/A
: Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
: SB serves as principal investigator of Alexion M11–001 atypical Haemolytic Uraemic Syndrome international registry and served on teaching courses for Alexion Pharmaceuticals. JF serves as co-investigator of Alexion M11–001 atypical Haemolytic Uraemic Syndrome international registry. VF-B served on advisory boards and in teaching courses for Alexion Pharmaceuticals and serves as coordinator of the scientific advisory board of Alexion M11–001 atypical Haemolytic Uraemic Syndrome international registry.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.